Heterozygous pathogenic variants involving CBFB cause a new skeletal disorder resembling cleidocranial dysplasia
Open Access
- 14 October 2022
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 60 (5) , 498-504
Abstract
Background: Cleidocranial dysplasia (CCD) is a rare skeletal dysplasia with significant clinical variability. Patients with CCD typically present with delayed closure of fontanels and cranial sutures, dental anomalies, clavicular hypoplasia or aplasia and short stature. Runt-related transcription factor 2 (RUNX2) is currently the only known disease-causing gene for CCD, but several studies have suggested locus heterogeneity. Methods: The cohort consists of eight subjects from five unrelated families partially identified through GeneMatcher. Exome or genome sequencing was applied and in two subjects the effect of the variant was investigated at RNA level. Results: In each subject a heterozygous pathogenic variant in CBFB was detected, whereas no genomic alteration involving RUNX2 was found. Three CBFB variants (one splice site alteration, one nonsense variant, one 2 bp duplication) were shown to result in a premature stop codon. A large intragenic deletion was found to delete exon 4, without affecting CBFB expression. The effect of a second splice site variant could not be determined but most likely results in a shortened or absent protein. Affected individuals showed similarities with RUNX2-related CCD, including dental and clavicular abnormalities. Normal stature and neurocognitive problems were however distinguishing features. CBFB encodes the core-binding factor β subunit, which can interact with all RUNX proteins (RUNX1, RUNX2, RUNX3) to form heterodimeric transcription factors. This may explain the phenotypic differences between CBFB-related and RUNX2-related CCD. Conclusion: We confirm the previously suggested locus heterogeneity for CCD by identifying five pathogenic variants in CBFB in a cohort of eight individuals with clinical and radiographic features reminiscent of CCD.Keywords
Funding Information
- Methusalem-OEC grant (GENOMED (Grant Number: FFB190208))
This publication has 42 references indexed in Scilit:
- Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcomeAmerican Journal of Medical Genetics Part A, 2006
- Cleidocranial dysplasia: Molecular genetic analysis and phenotypic‐based description of a Middle European patient groupAmerican Journal of Medical Genetics Part A, 2005
- Large fontanelles are a shared feature of haploinsufficiency of RUNX2 and its co‐activator CBFBCongenital Anomalies, 2004
- Dentomaxillofacial variability of cleidocranial dysplasia: clinicoradiological presentation and systematic reviewDentomaxillofacial Radiology, 2003
- Cbfβ interacts with Runx2 and has a critical role in bone developmentNature Genetics, 2002
- Core-binding factor β interacts with Runx2 and is required for skeletal developmentNature Genetics, 2002
- Cleidocranial dysplasia associated with a t(6;18)(p12;q24) translocationAmerican Journal of Medical Genetics, 1995
- High resolution mapping of interstitial long arm deletions of chromosome 16: relationship to phenotype.Journal of Medical Genetics, 1993
- Pericentric inversion of chromosome 6 in a patient with cleidocranial dysplasiaAmerican Journal of Medical Genetics, 1993
- Interstitial deletion of chromosome 16q: 16q22 is critical for 16q- syndromeAmerican Journal of Medical Genetics, 1992